Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia

Author： Saloustros Emmanouil Tryfonidis Kostas Georgoulias Vassilis

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.6, 2011-04, pp. : 851-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia

By Rofail Pierre Tadros Mariam Ywakim Riham Tadrous Mina Krug Allison Cosler Leon E

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 12, Iss. 6, 2012-12 ,pp. : 699-709

Informa Healthcare

Access to resources Recommend Favorite

Assess the risk of chemotherapy-induced nausea and vomiting, then choose the appropriate prophylactic regimen

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 17-21

Adis International

Access to resources Recommend Favorite

Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies

Current Medicinal Chemistry, Vol. 15, Iss. 29, 2008-12 ,pp. : 3081-3094

Bentham Science Publishers

Access to resources Recommend Favorite

Lenograstim: An Update of its Pharmacological Properties and Use in Chemotherapy-Induced Neutropenia and Related Clinical Settings

By Dunn C.J. Goa K.L.

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 681-717

Adis International

Access to resources Recommend Favorite

Economic Evaluations of Granulocyte Colony-Stimulating Factor: In the Prevention and Treatment of Chemotherapy-Induced Neutropenia

By Esser M. Brunner H.

PharmacoEconomics, Vol. 21, Iss. 18, 2003-01 ,pp. : 1295-1313

Adis International

Access to resources Recommend Favorite